These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 547123)

  • 1. The inhibition of rat brain monoamine oxidase-B by J-508 (N-methyl-N-propargyl-(1-indanyl)-ammonium hydrochloride), and its use for the titration of this enzyme form.
    Fowler CJ; Oreland L; Wiberg A; Carlsson A; Magnusson T
    Med Biol; 1979; 57(6):406-11. PubMed ID: 547123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Titration of human brain type-B monoamine oxidase.
    Fowler CJ; Wiberg A; Oreland L; Winblad B
    Neurochem Res; 1980 Jul; 5(7):697-708. PubMed ID: 7422056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].
    Schraven E; Reibert R
    Arzneimittelforschung; 1984; 34(10):1258-60. PubMed ID: 6542783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508].
    Miklya I
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):15-22. PubMed ID: 18771016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 7. Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B.
    Silvestri R; La Regina G; De Martino G; Artico M; Befani O; Palumbo M; Agostinelli E; Turini P
    J Med Chem; 2003 Mar; 46(6):917-20. PubMed ID: 12620068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of new 2-propinylamine derivatives on mitochondrial monoamine oxidase activity].
    Shatemirova KK; Davydova GA; Verevkina IV; Tichilkin AI
    Vopr Med Khim; 1977; 23(5):609-18. PubMed ID: 595495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease?
    Tabakman R; Lecht S; Lazarovici P
    Bioessays; 2004 Jan; 26(1):80-90. PubMed ID: 14696044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease.
    Weinstock M; Gorodetsky E; Poltyrev T; Gross A; Sagi Y; Youdim M
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):555-61. PubMed ID: 12787840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of brain monoamine oxidase by 1,2,4-trisubstituted 5-imidazolones.
    Kumar S; Pandey BR; Parmar SS; Gallagher JR; Mayer GG
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):163-6. PubMed ID: 6729247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of the "B form" of monoamine oxidase.
    Magyar K; Knoll J
    Pol J Pharmacol Pharm; 1977; 29(3):233-46. PubMed ID: 887501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of ethanol consumption on the sensitivity of rat brain monoamine oxidases to the inhibition by pargyline in vivo and in vitro.
    Panova NG; Axenova LN; Medvedev AE
    Neurobiology (Bp); 2000; 8(3-4):225-30. PubMed ID: 11225512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of monoamine oxidase B in complex with four inhibitors of the N-propargylaminoindan class.
    Binda C; Hubálek F; Li M; Herzig Y; Sterling J; Edmondson DE; Mattevi A
    J Med Chem; 2004 Mar; 47(7):1767-74. PubMed ID: 15027868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression.
    Weinstock M; Poltyrev T; Bejar C; Youdim MB
    Psychopharmacology (Berl); 2002 Mar; 160(3):318-24. PubMed ID: 11889501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.